Cite
HARVARD Citation
Vollmer, B. et al. (2020). Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment. Annals of clinical and translational neurology. 7 (9), pp. 1466-1476. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vollmer, B. et al. (2020). Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment. Annals of clinical and translational neurology. 7 (9), pp. 1466-1476. [Online].